Vanguard Group Inc. Has $1.83 Billion Stock Position in Tenet Healthcare Corporation $THC

Vanguard Group Inc. trimmed its holdings in Tenet Healthcare Corporation (NYSE:THC) by 4.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,009,590 shares of the company’s stock after selling 452,814 shares during the period. Vanguard Group Inc. owned about 10.25% of Tenet Healthcare worth $1,829,307,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of THC. Pallas Capital Advisors LLC grew its position in Tenet Healthcare by 38.1% in the third quarter. Pallas Capital Advisors LLC now owns 6,207 shares of the company’s stock worth $1,260,000 after acquiring an additional 1,713 shares in the last quarter. State of New Jersey Common Pension Fund D lifted its holdings in Tenet Healthcare by 2.3% in the third quarter. State of New Jersey Common Pension Fund D now owns 32,174 shares of the company’s stock worth $6,533,000 after buying an additional 722 shares during the period. HighTower Advisors LLC grew its stake in Tenet Healthcare by 9.5% in the third quarter. HighTower Advisors LLC now owns 11,188 shares of the company’s stock worth $2,272,000 after purchasing an additional 971 shares during the period. GenTrust LLC purchased a new stake in shares of Tenet Healthcare in the 3rd quarter worth about $895,000. Finally, Leuthold Group LLC grew its holdings in Tenet Healthcare by 3.5% in the third quarter. Leuthold Group LLC now owns 29,872 shares of the company’s stock worth $6,065,000 after purchasing an additional 1,015 shares during the period. 95.44% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director directly owned 28,480 shares in the company, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.81% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on THC. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. Jefferies Financial Group upped their price target on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. KeyCorp upped their price objective on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research note on Thursday, February 12th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and set a $265.00 target price on shares of Tenet Healthcare in a report on Monday. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $246.71.

Tenet Healthcare Trading Down 1.8%

NYSE THC opened at $227.68 on Friday. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $235.77. The firm’s 50-day moving average is $201.26 and its two-hundred day moving average is $196.69. The stock has a market capitalization of $19.80 billion, a P/E ratio of 14.70, a PEG ratio of 1.14 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. During the same period last year, the business posted $3.44 earnings per share. The firm’s revenue for the quarter was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, sell-side analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.